Our results suggest previous assessments of pathogenic constitutional variants underlying CNS tumor development (in approximately 10% of patients) to appear broadly robust15 and an enrichment of Li–Fraumeni syndrome, Lynch syndrome and constitutional MMR deficiency underlying H3 wild-type HGG. This evidence concerns the gene FGFR1 and hyperinsulinemic hypoglycemia, familial, 4.